Wheeler Emily A, Lenhart-Pendergrass Patricia M, Rysavy Noel M, Poch Katie, Caceres Silvia, Calhoun Kara M, Serban Karina, Nick Jerry A, Malcolm Kenneth C
Department of Medicine, National Jewish Health, Denver, CO.
Department of Pediatrics, University of Colorado, Aurora, CO.
bioRxiv. 2023 May 16:2023.05.15.540822. doi: 10.1101/2023.05.15.540822.
is a nontuberculous mycobacterium emerging as a significant pathogen for individuals with chronic lung disease, including cystic fibrosis and chronic obstructive pulmonary disease. Current therapeutics have poor efficacy. New strategies of bacterial control based on host defenses are appealing, but anti-mycobacterial immune mechanisms are poorly understood and are complicated by the appearance of smooth and rough morphotypes with distinct host responses. We explored the role of the complement system in the clearance of morphotypes by neutrophils, an abundant cell in these infections. opsonized with plasma from healthy individuals promoted greater killing by neutrophils compared to opsonization in heat-inactivated plasma. Rough clinical isolates were more resistant to complement but were still efficiently killed. Complement C3 associated strongly with the smooth morphotype while mannose-binding lectin 2 was associated with the rough morphotype. M. abscessus killing was dependent on C3, but not on C1q or Factor B; furthermore, competition of mannose-binding lectin 2 binding with mannan or N-acetyl-glucosamine during opsonization did not inhibit killing. These data suggest that does not canonically activate complement through the classical, alternative, or lectin pathways. Complement-mediated killing was dependent on IgG and IgM for smooth and on IgG for rough . Both morphotypes were recognized by Complement Receptor 3 (CD11b), but not CR1 (CD35), and in a carbohydrate- and calcium-dependent manner. These data suggest the smooth-to-rough adaptation changes complement recognition of and that complement is an important factor for infection.
脓肿分枝杆菌是一种非结核分枝杆菌,正成为慢性肺病患者(包括囊性纤维化和慢性阻塞性肺病患者)的重要病原体。目前的治疗方法疗效不佳。基于宿主防御的细菌控制新策略很有吸引力,但抗分枝杆菌免疫机制了解甚少,且由于出现具有不同宿主反应的光滑和粗糙形态型而变得复杂。我们探讨了补体系统在中性粒细胞清除这些形态型中的作用,中性粒细胞是这些感染中数量丰富的细胞。与热灭活血浆中的调理作用相比,用健康个体的血浆进行调理可促进中性粒细胞的更大杀伤作用。粗糙的临床分离株对补体更具抗性,但仍能被有效杀伤。补体C3与光滑形态型密切相关,而甘露糖结合凝集素2与粗糙形态型相关。脓肿分枝杆菌的杀伤依赖于C3,但不依赖于C1q或因子B;此外,在调理过程中,甘露糖结合凝集素2与甘露聚糖或N-乙酰葡糖胺的结合竞争并不抑制杀伤作用。这些数据表明,脓肿分枝杆菌不会通过经典、替代或凝集素途径典型地激活补体。补体介导的杀伤作用对于光滑形态型依赖于IgG和IgM,对于粗糙形态型依赖于IgG。两种形态型均被补体受体3(CD11b)识别,但不被CR1(CD35)识别,且以碳水化合物和钙依赖的方式被识别。这些数据表明,从光滑到粗糙的适应性变化改变了补体对脓肿分枝杆菌的识别,并且补体是脓肿分枝杆菌感染的一个重要因素。